openPR Logo
Press release

Global Transdermal Market Trends Demand Clinical Trials Pipeline Sales Opportunity Insight 2026

05-09-2020 04:01 PM CET | Health & Medicine

Press release from: Kuick Resarch

The research report "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" provides a comprehensive outlook about the wide applications that this delivery system in providing to the patients all over the globe. The research report also focuses towards introducing this delivery system and how it is contributing to relive the patients from the pain that the other drug delivery system provides in an elaborated way. In addition to the general information about the transdermal patches, the research report successfully delivers the information about the increasing interest of the pharmaceutical companies towards launching and marketing novel transdermal patches in the market towards different indications.

"Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights:

o Global Transdermal Patch Market Opportunity: > US$ 15 Billion
o Global Transdermal Patch Clinical Pipeline: 100 Patches In Trials
o Clinical Insight on 66 Commercially/Marketed Transdermal Patches
o Global Transdermal Patch Clinical Trials Insight by Company, Drug Class, Indication & Patent Information
o Regional Trends & Market Insight: US, Europe & Asia-Pacific
o Dosage & Price Insight on Transdermal Patch
o Global Transdermal Patch Market Future Prospects

Download Report: https://www.kuickresearch.com/report-global-transdermal-patch-market,-dosage,-price-and-clinical-trials-insight-2026.php

Falling in the class of transdermal technology, the arrival of transdermal patches has gained appreciation all around the world. It is among the classes of drug delivery system that has been adopted for majority of the indications. Through the means of transdermal patches, the drugs required by the patient are administered through skin. It not only enhances the delivery of the drug inside the body but also relieves the suffering that the patient requires to undergo by any other mode of drug delivery such as injections/syringes.

Since the arrival of this mode of drug delivery in the market, the patients, clinicians as well as non-clinicians are more inclined towards it because there are certain advantages and applications associated with such type of drug delivery method. Transdermal patches user-friendly, painless, and convenient and its ability to offer multi-day dosing have made this mode of drug delivery accepted in all the hospitals and medical care center.

Not only these patches are effective against a single indication but they have shown promising results for a number of indications such as Alzheimer's disease, strokes, HIV, dermatology related issues, migraine and Parkinson's disease. The ability of transdermal patches for various indications is the progress that it has made in a short period of time. By observing the growth it has made in the past few decades, several pharmaceutical companies are growing their interest towards developing more efficient patches for other indications.

According to the research conducted by KuicK Research, it has been analyzed that there will be a significant growth in the market in the coming time period as more of the patients are getting inclined towards the drug delivery system that are painless and non-invasive. The growing interest of the clinicians as well as non-clinicians towards pain-free drug delivery is driving the market of transdermal patches. All these mentioned factors above are expected to widen up the scope for the growth of the respective market in the coming years.

Table of Contents

1. Prologue to Transdermal Patch
1.1 Overview of Transdermal Patch
1.2 Relevance of Transdermal Patch

2. Types of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

3. Mechanism of Transdermal Patch Drug Delivery
3.1 Properties of Transdermal Therapeutics
3.2 Components of Transdermal Patch
3.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods

4. Global Transdermal Patch Market Insight
4.1 Global Market Scenario
4.2 Regional Market Trends
4.2.1 United States
4.2.2 Europe
4.2.3 Asia Pacific

5. Transdermal Patches for Cardiovascular Diseases - Availability, Dosage & Price Analysis
5.1 Clonidine Transdermal Patch (Catapres-TTS)
5.2 Nitro Glycerin Transdermal Patch
6. Opioid Drug Containing Transdermal Patches - Availability, Dosage & Price Analysis
6.1 Fentanyl Transdermal Patch (Duragesic)
6.2 Buprenorphine Transdermal Patch (Butrans Patch)

7. Transdermal Patches for Neurological Disorders - Availability, Dosage & Price Analysis
7.1 Selegiline Transdermal Patch (Emsam)
7.2 Scopolamine Transdermal Patch (Transderm-Scop)
7.3 Rivastigmine Transdermal Patch (Exelon)
7.4 Methylphenidate Transdermal Patch (Daytrana)

8. Transdermal Patch in Hormonal Therapy - Availability, Dosage & Price Analysis
8.1 Estradiol Transdermal Patch
8.1.1 Alora
8.1.2 Vivelle-Dot
8.2 Testosterone Transdermal Patch (Androderm)
8.3 Ethinyl Estradiol & Norelgestromin Transdermal Patch (Xulane)

9. Transdermal Patches for Other Conditions - Availability, Dosage & Price Analysis
9.1 Nicotine Transdermal Patch (Nicoderm CQ)
9.2 Oxybutynin Transdermal Patch (Oxytrol)

10. Global Transdermal Patch Clinical Pipeline Overview
10.1 By Phase
10.2 By Region/Country
10.3 By Drug Class/Molecule
10.4 By Company
10.5 By Orphan & Fast Track Status
10.6 By Mode of Action

11. Global Patch Clinical Pipeline By Company, Indication & Phase
11.1 Unknown
11.2 Research
11.3 Preclinical
11.4 Clinical
11.5 Phase-I
11.6 Phase-I/II
11.7 Phase-II
11.8 Phase-III
11.9 Preregistration
11.10 Registered

12. Marketed Transdermal Patch Clinical Insight

13. Global Transdermal Patch Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges

14. Global Transdermal Patch Market Future Outlook 2026

15. Competitive Landscape
15.1 3M Pharmaceuticals
15.2 Acrux
15.3 Agile Therapeutics
15.4 Allergan
15.5 ANI Pharmaceuticals
15.6 Antares Pharma
15.7 Bayer HealthCare Pharmaceuticals
15.8 Corium International
15.9 Chase Pharmaceuticals
15.10 DURECT Corporation
15.11 Endo Pharmaceuticals
15.12 Fempharm
15.13 Hisamitsu Pharmaceutical
15.14 Immune Pharmaceuticals
15.15 Imprimis Pharmaceuticals
15.16 Ipsen Bioscience
15.17 Johnson & Johnson
15.18 LaSalle Laboratories
15.19 Lavipharm-increase
15.20 MINRAD International
15.21 NeurogesX
15.22 Noven Pharmaceuticals
15.23 NuPathe
15.24 Nuvo Research
15.25 Novartis
15.26 Pain Therapeutics
15.27 ProStrakan
15.28 Purdue Pharma
15.29 Sanofi
15.30 Scilex Pharmaceuticals
15.31 Senju Pharmaceutical
15.32 Somerset Pharmaceuticals
15.33 Teikoku Seiyaku
15.34 Therapeutic Discovery Corporation
15.35 Transdermal Delivery Solutions Corp
15.36 UCB
15.37 Xel Pharmaceuticals
15.38 Zosano Pharma

Delhi
India

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Transdermal Market Trends Demand Clinical Trials Pipeline Sales Opportunity Insight 2026 here

News-ID: 2040006 • Views: 577

More Releases from Kuick Resarch

Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy
Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …
Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027 "Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market: > USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Cell Therapy Price & Product Insight By Region/Country • Clinical
Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …
"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026 • USA Dominates Global Small Molecule Cancer Drug Market: >50% Share • Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs • Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs • Small Molecule Drug Insight by Cancer • Clinical Trials Insight
GCC Clinical Trial Market Outlook Insight 2025
"GCC Clinical Trial Market Outlook 2025" Report Highlights: • GCC Clinical Trial Market Opportunity: >US$ 500 Million • GCC Disease Prevalence & Statistics • Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials • Clinical Trials for Cancer in GCC: > 120 Trials • Guidelines For Conducting Clinical Trials by Country • Ongoing Clinical Trials Insight by Country Download Report: https://www.kuickresearch.com/report-report-report-report-report-report-report-report-gcc-clinical-trial-market-size-number--data-regulation-registration Table of Contents 1. GCC Clinical Market Regional Insights 2. GCC Clinical Trial Market Dynamics 2.1 Driving Forces for GCC Clinical Trial

All 5 Releases


More Releases for Patch

Global Insulin Patch Pump Market Insights, Forecast
For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body. The global Insulin Patch Pump market is valued at xx million US$ in 2018 and will reach
Paw Patch Pastries' New Location
San Francisco, CA – Paw Patch Pastries and Pet Boutique, the provider of upscale pet treats, custom cakes, and adorable toys, has moved to the fitting “Dog Patch” area of San Francisco. The new location at 701 Pennsylvania Avenue was officially open for business on August 2. This unique boutique is the pawfect spot to pamper your pooch or kitty, offering daily baked goods and sweet treats as well as
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
United States Nicotine Patch Market Report 2017
In this report, the United States Nicotine Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Nicotine Patch in these
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3
Global Insulin Patch Market Opportunity Analysis
Transdermal drug delivery is one of the oldest methods that have been used by physicians to alleviate patients medical condition. Patches are recent inventions of pharmaceutical companies for those patient populations who can’t be administered with conventional drugs. They are applied over the skin from which drug is released in controlled manner followed by entry into the body. Topical drugs are also applied on skin but their effect is local